investordatabase.org

Revere Partners

reverepartnersvc.com Direct investor

Revere Partners is a venture capital firm focused on early-stage oral health technology companies. It invests across software, fintech, biotech, medtech, specialty products and services, and also offers corporate services, an SPV platform and fund administration services.

Revere Partners is a venture capital firm. It invests directly in companies, from seed to Series B, in oral health, software, fintech and biotech.

“Our global focus on Seed through Series B stages allows us to actively shape these groundbreaking companies while remaining open to engaging with exceptional founders at any stage.”

— Revere Partners, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series B
Invests in
Europe, Asia, North America, South America
Sectors
oral health, software, fintech, biotech, medtech, specialty products, services

Team, as Revere Partners publishes it

  • Dr. Jeremy Krell Founder & Managing Partner
  • David Arena Chief Financial Officer & General Partner
  • Dominik Lysek, PhD Chief Science Officer
  • Johnny de Gruiter Director of Investments
  • Kelsey Kephart Head of Business Operations
  • Immi Sivia Head of Investor Relations
  • Rahul Tulsyani Portfolio Success Associate
  • Dr. Kathy O’Loughlin Venture Partner
  • Dr. Edward J. Zuckerberg Venture Partner
  • Dr. Yan Kalika Venture Partner
  • Dr. Miguel Stanley Venture Partner

Names and roles exactly as listed on reverepartnersvc.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Revere Partners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 14992 · added 2026-10-20 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under